Ken Griffin Lemaitre Vascular Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$80.3 - $92.89 $128,480 - $148,624	1,600 Added 44.44%	5,200 $483,000
Q2 2024 Aug 14, 2024	SELL	$62.62 - $83.59 $31,310 - $41,795	-500 Reduced 12.2%	3,600 $296,000
Q1 2024 May 15, 2024	SELL	$54.0 - $71.06 $70,200 - $92,378	-1,300 Reduced 24.07%	4,100 $272,000
Q4 2023 Feb 14, 2024	SELL	$45.37 - $58.41 $131,573 - $169,389	-2,900 Reduced 34.94%	5,400 $306,000
Q3 2023 Nov 14, 2023	BUY	$53.45 - $67.01 $422,255 - $529,379	7,900 Added 1975.0%	8,300 $452,000
Q2 2023 Aug 14, 2023	BUY	$50.38 - $68.21 $15,114 - $20,462	300 Added 300.0%	400 $26,000
Q1 2023 May 15, 2023	BUY	$44.73 - $51.68 $4,473 - $5,168	100 New	100 $5,000

291

20.4M

5.2K

2.9K

Ticker LMAT
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 21,962,900
Market Cap $2.04B
Description
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.